Karolina Jablonska, Jedrzej Grzegrzolka, Marzenna Podhorska-Okolow, Mariusz Stasiolek, Bartosz Pula, Mateusz Olbromski, Agnieszka Gomulkiewicz, Aleksandra Piotrowska, Janusz Rys, Aleksandra Ambicka, Siew Hwa Ong, Maciej Zabel, Piotr Dziegiel: Prolactin-induced protein as a potential therapy response marker of adjuvant chemotherapy in breast cancer patients. Am J Cancer Res 2016;6(5):878-893. (Full text, PDF)
Gaurav Kumar, Jagan Mohan R Patlolla, Venkateshwar Madka, Altaf Mohammed, Qian Li, Yuting Zhang, Laura Biddick, Anil Singh, Allison Gillaspy, Stanley Lightfoot, Vernon E Steele, Levy Kopelovich, Chinthalapally V Rao: Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice. Am J Cancer Res 2016;6(5):894-909. (Full text, PDF)
Satadru K Lahiri, Heng Lu, Debarati Mukherjee, Lin Yu, Jihe Zhao: ERK2 phosphorylates Krüppel-like factor 8 protein at serine 48 to maintain its stability. Am J Cancer Res 2016;6(5):910-923. (Full text, PDF)
Xuefeng Bu, Yinghai Zhao, Zhijian Zhang, Mubin Wang, Mi Li, Yulan Yan: Recombinant Newcastle disease virus (rL-RVG) triggers autophagy and apoptosis in gastric carcinoma cells by inducing ER stress. Am J Cancer Res 2016;6(5):924-936. (Full text, PDF)
Hang-Ping Yao, Liang Feng, Jian-Wei Zhou, Rui-Wen Zhang, Ming-Hai Wang: Therapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment. Am J Cancer Res 2016;6(5):937-956. (Full text, PDF)
Taolan Zhang, Yingying Shao, Tang-Yuan Chu, Hsuan-Shun Huang, Yu-Ligh Liou, Qing Li, Honghao Zhou: MiR-135a and MRP1 play pivotal roles in the selective lethality of phenethyl isothiocyanate to malignant glioma cells. Am J Cancer Res 2016;6(5):957-972. (Full text, PDF)
Katarina Kolostova, Michael Pinkas, Anna Jakabova, Eliska Pospisilova, Pavla Svobodova, Jan Spicka, Martin Cegan, Rafal Matkowski, Vladimir Bobek: Molecular characterization of circulating tumor cells in ovarian cancer. Am J Cancer Res 2016;6(5):973-980. (Full text, PDF)
Sunil Acharya, Jia Xu, Xiao Wang, Shalini Jain, Hai Wang, Qingling Zhang, Chia-Chi Chang, Joseph Bower, Banu Arun, Victoria Seewaldt, Dihua Yu: Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinib. Am J Cancer Res 2016;6(5):981-995. (Full text, PDF)
Chao Wang, Kangjin Jeong, Hongyuan Jiang, Wei Guo, Chao Gu, Yiling Lu, Jiyong Liang: YAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer. Am J Cancer Res 2016;6(5):996-1010. (Full text, PDF)
Xingkai Liu, Ping Zhang, Robert C Martin, Guozhen Cui, Guangyi Wang, Yi Tan, Lu Cai, Guoyue Lv, Yan Li: Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice. Am J Cancer Res 2016;6(5):1011-1025. (Full text, PDF)
Wen-Si Zhao, Yi Luo, Bo-Yi Li, Han-Jing Zhou, Tao Zhang: Anti-ABCG2 scFv antibody of lung adenocarcinoma increases chemosensitivity and induces apoptosis through the activation of mitochondrial pathway. Am J Cancer Res 2016;6(5):1026-1039. (Full text, PDF)
Zong Xin Zhang, Wen Jun Jin, Sheng Yang, Cun Li Ji: BRAF kinase inhibitor exerts anti-tumor activity against breast cancer cells via inhibition of FGFR2. Am J Cancer Res 2016;6(5):1040-1052. (Full text, PDF)
Xiang Zhang, Yueyun Ma, Hua Wei, Bin Li, Fengjing Xiao, Jing Yang, Qiaohong Yue, Angang Yang, Xiaoke Hao: A prostate-specific antigen-dependent fusion polypeptide inhibits growth of prostate cancer cells in vitro and in vivo. Am J Cancer Res 2016;6(5):1053-1065. (Full text, PDF)
Elsa M Reyes-Reyes, Irma N Ramos, Marco A Tavera-Garcia, Kenneth S Ramos: The aryl hydrocarbon receptor agonist benzo(a)pyrene reactivates LINE-1 in HepG2 cells through canonical TGF-β1 signaling: implications in hepatocellular carcinogenesis. Am J Cancer Res 2016;6(5):1066-1077. (Full text, PDF)
Kyung-Mi Bae, Yao Dai, Johannes Vieweg, Dietmar W Siemann: Hypoxia regulates SOX2 expression to promote prostate cancer cell invasion and sphere formation. Am J Cancer Res 2016;6(5):1078-1088. (Full text, PDF)
Yanfang Zhang, Kexia Wu, Yuan Shao, Fang Sui, Qi Yang, Bingyin Shi, Peng Hou, Meiju Ji: Decreased 5-Hydroxymethylcytosine (5-hmC) predicts poor prognosis in early-stage laryngeal squamous cell carcinoma. Am J Cancer Res 2016;6(5):1089-1098. (Full text, PDF)
Jipeng Li, Jianhua Wang, Yin Chen, Shanfeng Li, Mingwei Jin, Huaying Wang, Zhe Chen, Wanjun Yu: LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204. Am J Cancer Res 2016;6(5):1099-1107. (Full text, PDF)
Shaojia Wang, Jie Xie, Jiajia Li, Fei Liu, Xiaohua Wu, Ziliang Wang: Cisplatin suppresses the growth and proliferation of breast and cervical cancer cell lines by inhibiting integrin β5-mediated glycolysis. Am J Cancer Res 2016;6(5):1108-1117. (Full text, PDF)
Hung-Yen Lee, Kamal A Mohammed, Najmunnisa Nasreen: Nanoparticle-based targeted gene therapy for lung cancer. Am J Cancer Res 2016;6(5):1118-1134. (Full text, PDF)
Hong Yu, Hui Li,Yongan Cui, Wei Xiao, Guihong Dai, Junxing Huang, Chaofu Wang: The mRNA level of MLH1 in peripheral blood is a biomarker for the diagnosis of hereditary nonpolyposis colorectal cancer. Am J Cancer Res 2016;6(5):1135-1140. (Full text, PDF)
Yi-Xing Gao, Lu Chen, Xu-Gang Hu, Hai-Bo Wu, You-Hong Cui, Xia Zhang, Yan Wang, Xin-Dong Liu, Xiu-Wu Bian: ATPase inhibitory factor 1 expression is an independent prognostic factor in non-small cell lung cancer. Am J Cancer Res 2016;6(5):1141-1148. (Full text, PDF)
